世界のファーマコビジランス市場予測2023年-2028年

【英語タイトル】Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料(IMARC23DCB0301)・商品コード:IMARC23DCB0301
・発行会社(調査会社):IMARC
・発行日:2023年11月
・ページ数:147
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

世界のファーマコビジランス市場規模は2022年に73億ドルに達しました。IMARCグループは、2022年から2028年にかけて8.8%の成長率(CAGR)を示し、2028年には121億ドルに達すると予測しています。
ファーマコビジランス(PV)は、医薬品による好ましくない影響の検出、評価、理解、予防に関する薬理学的科学です。これまで知られていなかった副作用を特定し、頻度や重症度の変化を認識し、医薬品のリスクとベネフィットを評価して必要な措置を決定する上で極めて重要な役割を果たす。また、医療従事者や患者に伝達される情報の正確性も保証されます。現在、PVは医薬品が個人に及ぼす影響を理解するために世界中で広く利用されています。

ファーマコビジランス市場の動向
高血圧、糖尿病、心疾患などの生活習慣病の増加により、世界中で医薬品の消費量が増加しています。これは、医薬品副作用(ADR)の発生件数の増加と相まって、世界のファーマコビジランス市場を牽引する重要な要因の一つとなっています。これに加えて、主要企業はADR報告の自動化を確実にするために先進的なプラットフォームを導入しており、これが市場の成長に寄与しています。また、競争環境を背景に、製造業務の改善や研究開発(R&D)の効率化にも注力しています。さらに、大手製薬企業は、臨床試験を実施し、医薬品の適切な使用に関する意識を高めるために数多くの取り組みを行っています。これが、ファーマコビジランス市場の成長を促進しています。さらに、コロナウイルス感染症(COVID-19)の大流行により、ワクチンが緊急に必要とされるようになり、市場関係者に多くのビジネスチャンスをもたらしています。これとは別に、製薬メーカーはファーマコビジランス業務を第三者にアウトソーシングする方向にシフトしており、その理由としては、社内リソースの柔軟性の向上や短期間での成果の向上など、関連する利点があるためです。

主な市場セグメンテーション
IMARC Groupは、世界のファーマコビジランス市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、サービスプロバイダー、製品ライフサイクル、タイプ、プロセスフロー、治療分野、最終用途に基づいて市場を分類しています。

サービスプロバイダー別内訳
インハウス
アウトソーシング契約

製品ライフサイクル別
前臨床
第I相
フェーズII
フェーズIII
フェーズIV

タイプ別
自発的報告
ADR報告の強化
目標設定された自発報告
コホートイベントモニタリング
EHRマイニング

プロセスフロー別
症例データ管理
症例ロギング
症例データ分析
医療レビューと報告
シグナル検出
有害事象の記録
有害事象分析
有害事象のレビューと報告
リスク管理システム
リスク評価システム
リスク軽減システム

治療領域別
がん領域
神経学
循環器
呼吸器系
その他

最終用途別
製薬会社
バイオテクノロジー企業
医療機器メーカー
その他

地域別
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境:
業界の競争環境は、Accenture plc、ArisGlobal LLC、BioClinica Inc. (Cinven Partners LLP)、Capgemini、Cognizant、International Business Machines Corporation、ICON plc.、IQVIA Inc.、ITClinical、Parexel International Corporation、Wipro Limitedなどの主要企業のプロフィールと共に調査されています。

本レポートで扱う主な質問
世界のファーマコビジランス市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
COVID-19が世界のファーマコビジランス市場に与えた影響は?
主要な地域市場は?
サービスプロバイダーに基づく市場の内訳は?
製品ライフサイクルに基づく市場の内訳は?
タイプ別の市場構成は?
プロセスフローに基づく市場の内訳は?
治療領域に基づく市場の内訳は?
最終用途に基づく市場の内訳は?
業界のバリューチェーンにおける様々な段階とは?
業界の主な推進要因と課題は何か?
世界のファーマコビジランス市場の構造と主要プレーヤーは?
業界における競争の程度は?

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界のファーマコビジランス市場
6. ファーマコビジランスの世界市場規模:サービスプロバイダー別
7. ファーマコビジランスの世界市場規模:製品ライフサイクル別
8. ファーマコビジランスの世界市場規模:種類別
9. ファーマコビジランスの世界市場規模:プロセスフロー別
10. ファーマコビジランスの世界市場規模:治療領域別
11. ファーマコビジランスの世界市場規模:エンドユーザー別
12. ファーマコビジランスの世界市場規模:地域別
13. SWOT分析
14. バリューチェーン分析
15. ファイブフォース分析
16. 価格分析
17. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmacovigilance Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service Provider
6.1 In-house
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Contract Outsourcing
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Life Cycle
7.1 Pre-clinical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Phase I
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Phase II
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Phase III
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Phase IV
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Type
8.1 Spontaneous Reporting
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intensified ADR Reporting
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Targeted Spontaneous Reporting
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cohort Event Monitoring
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 EHR Mining
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Process Flow
9.1 Case Data Management
9.1.1 Market Trends
9.1.2 Major Types
9.1.2.1 Case Logging
9.1.2.2 Case Data Analysis
9.1.2.3 Medical Reviewing and Reporting
9.1.3 Market Forecast
9.2 Signal Detection
9.2.1 Market Trends
9.2.2 Major Types
9.2.2.1 Adverse Event Logging
9.2.2.2 Adverse Event Analysis
9.2.2.3 Adverse Event Review and Reporting
9.2.3 Market Forecast
9.3 Risk Management System
9.3.1 Market Trends
9.3.2 Major Types
9.3.2.1 Risk Evaluation System
9.3.2.2 Risk Mitigation System
9.3.3 Market Forecast
10 Market Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurology
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Cardiology
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Respiratory Systems
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by End Use
11.1 Pharmaceuticals Companies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Biotechnology Companies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Medical Device Companies
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Others
11.4.1 Market Trends
11.4.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Accenture plc
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 ArisGlobal LLC
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.3 BioClinica Inc. (Cinven Partners LLP)
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 SWOT Analysis
17.3.4 Capgemini
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.5 Cognizant
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 International Business Machines Corporation
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 ICON plc.
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 IQVIA Inc.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 ITClinical
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.10 Parexel International Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 SWOT Analysis
17.3.11 Wipro Limited
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.11.3 Financials
17.3.11.4 SWOT Analysis

Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2022
Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2022
Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2022
Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2022
Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2022
Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2022
Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2022
Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2022
Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis

Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2023-2028
Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2023-2028
Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2023-2028
Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 9: Global: Pharmacovigilance Market: Competitive Structure
Table 10: Global: Pharmacovigilance Market: Key Players

★調査レポート[世界のファーマコビジランス市場予測2023年-2028年] (コード:IMARC23DCB0301)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のファーマコビジランス市場予測2023年-2028年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆